FOLH1 and glioblastoma: This review comprehensively addresses PET radiotracers and recent advances in neurotheranostics for GBM including integrin receptor family, prostate-specific membrane antigen (PSMA), fibroblast activated protein (FAP), somatostatin receptors (SRS), and chemokine receptor-4 (CXCR4).